Cairn Investment Group, Inc. Eli Lilly & CO Transaction History

Cairn Investment Group, Inc.

$181 Million
Q3 2024

A detailed history of Cairn Investment Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Cairn Investment Group, Inc. holds 3,530 shares of LLY stock, worth $2.7 Million. This represents 1.73% of its overall portfolio holdings.

Number of Shares

3,530

Previous 3,645 3.16%

Holding current value

$2.7 Million

Previous $3.3 Million 5.24%

% of portfolio

1.73%

Previous 1.93%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$772.14 - $960.02 $88,796 - $110,402	-115 Reduced 3.16%	3,530 $3.13 Million
Q2 2024 Aug 06, 2024	BUY	$724.87 - $909.04 $47,116 - $59,087	65 Added 1.82%	3,645 $3.3 Million
Q1 2024 Apr 15, 2024	SELL	$592.2 - $792.28 $236,880 - $316,912	-400 Reduced 10.05%	3,580 $2.79 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $13,654 - $16,097	-26 Reduced 0.65%	3,980 $2.32 Million
Q3 2023 Nov 06, 2023	BUY	$434.7 - $599.3 $11,302 - $15,581	26 Added 0.65%	4,006 $2.15 Million
Q1 2023 Apr 24, 2023	SELL	$310.63 - $364.82 $81,074 - $95,218	-261 Reduced 6.15%	3,980 $1.37 Million
Q4 2022 Jan 11, 2023	BUY	$321.55 - $374.67 $199,682 - $232,670	621 Added 17.15%	4,241 $1.55 Million
Q3 2022 Oct 13, 2022	SELL	$296.48 - $337.87 $128,968 - $146,973	-435 Reduced 10.73%	3,620 $1.17 Million
Q2 2022 Jul 28, 2022	SELL	$278.73 - $327.27 $720,795 - $846,320	-2,586 Reduced 38.94%	4,055 $1.32 Million
Q1 2022 Apr 26, 2022	SELL	$234.69 - $291.66 $2,346 - $2,916	-10 Reduced 0.15%	6,641 $2.39 Million
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $24,733 - $30,694	-110 Reduced 1.63%	6,651 $1.84 Million
Q2 2021 Aug 12, 2021	SELL	$180.55 - $233.54 $452,277 - $585,017	-2,505 Reduced 27.03%	6,761 $1.55 Million
Q1 2021 May 04, 2021	SELL	$164.32 - $212.72 $64,906 - $84,024	-395 Reduced 4.09%	9,266 $1.73 Million
Q4 2020 Feb 02, 2021	BUY	$130.46 - $172.63 $73,057 - $96,672	560 Added 6.15%	9,661 $1.63 Million
Q3 2020 Nov 02, 2020	SELL	$146.22 - $169.13 $35,092 - $40,591	-240 Reduced 2.57%	9,101 $1.35 Million
Q2 2020 Jul 21, 2020	SELL	$136.42 - $164.18 $98,904 - $119,030	-725 Reduced 7.2%	9,341 $1.53 Million
Q1 2020 Apr 24, 2020	SELL	$119.05 - $147.35 $5,357 - $6,630	-45 Reduced 0.45%	10,066 $1.4 Million
Q4 2019 Jan 30, 2020	BUY	$106.92 - $132.43 $1.08 Million - $1.34 Million	10,111 New	10,111 $1.33 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $727B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cairn Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cairn Investment Group, Inc. with notifications on news.

Account

Cairn Investment Group, Inc. Eli Lilly & CO Transaction History